Announced Thu, 9 Jul · 14:08 IST
Routine SEBI compliance certificate filed for Q1 FY27
Compliance View source PDF
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve
Awaiting price reaction for this filing.
AI summary
Ishita Drugs filed a routine quarterly compliance certificate under SEBI Regulation 74(5) for the quarter ended 30 June 2026. The certificate, issued by RTA Bigshare Services, confirms that all securities received for dematerialisation were processed, physical certificates cancelled, and depository names updated in the register of members within the required 15-day timeline. Signed by Managing Director Jagdish Agrawal.
Likely market impact
Routine procedural filing with no material impact on shareholders or share price.